1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association between the Khorana score and pulmonary embolism risk in patients with advanced stage lung cancer.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The Khorana score may help physicians to identify patients at high risk of Pulmonary embolism (PE) and decide who is eligible for thromboprophylaxis, however, its role in lung cancer patients remains unclear.

          Related collections

          Author and article information

          Journal
          Clin Respir J
          The clinical respiratory journal
          Wiley
          1752-699X
          1752-6981
          Jan 2020
          : 14
          : 1
          Affiliations
          [1 ] Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
          [2 ] Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
          [3 ] Department of Neurology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
          [4 ] Clinic of Chest diseases, Immunology and Allergology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
          [5 ] Centre of Pulmonology and Allergology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
          Article
          10.1111/crj.13092
          31585027
          664e4211-6191-49fb-8b88-75d2e87a7968
          © 2019 John Wiley & Sons Ltd.
          History

          chemotherapy,lung cancer,pulmonary embolism,risk assessment

          Comments

          Comment on this article